Personalized medicine: CCO's vision, accomplishments and future plans

Healthc Q. 2015:17 Spec No:41-3. doi: 10.12927/hcq.2014.24008.

Abstract

Personalized medicine is a rapidly expanding field, with the potential to improve patient care. Its benefits include increasing efficiency in cancer screening, diagnosis and treatment through early detection, targeted therapy and identifying individuals with an underlying genetic risk for cancer or adverse outcomes. Through the work of Cancer Care Ontario (CCO)'s Pathology and Laboratory Medicine Program, a number of initiatives have been undertaken to support developments in personalized medicine. In keeping with the momentum of recent accomplishments, CCO has led the formation of the Personalized Medicine Steering Committee to develop a comprehensive provincial genetics strategy for the future of cancer care.

MeSH terms

  • Forecasting
  • Humans
  • Medical Oncology / methods
  • Medical Oncology / organization & administration*
  • Medical Oncology / standards
  • Medical Oncology / trends
  • Neoplasms / therapy
  • Ontario
  • Precision Medicine / methods*
  • Precision Medicine / standards
  • Precision Medicine / trends
  • Quality Improvement